Multi-delay Arterial Spin Labeling Application in Acute Ischemic Stroke

Launched by XUANWU HOSPITAL, BEIJING · Jan 15, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new method called multi-delay arterial spin labeling (mD-ASL) to help diagnose acute ischemic stroke, which happens when blood flow to the brain is blocked. The goal is to see how well this non-invasive technique can measure blood flow in the brain compared to traditional methods. Researchers want to understand if this method can accurately identify areas of the brain affected by the stroke and how these measurements relate to patient recovery.

To participate in this trial, you must be between the ages of 65 and 74 and have experienced an ischemic stroke within the last 24 hours. Your stroke should be confirmed as an anterior circulation occlusion, which means the blockage is in a specific part of your brain. Unfortunately, if you are pregnant or cannot have an MRI scan for any reason, you won't be eligible to join. If you qualify, you can expect to undergo some tests that involve the mD-ASL method, and your results will contribute to understanding how this new approach can help in diagnosing and treating strokes more effectively.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Ischemic stroke within 24h；
• • 2. Anterior circulation occlusion confirmed by conventional angiography or magnetic resonance angiography；
• Exclusion Criteria:
• • 1. Pregnancy and other contraindication to MRI scan；
• • 2. Informed consent not obtained.